study question: What is the child morbidity after IVF in women who have received a kidney transplant? summary answer: Overall, obstetric outcome and morbidity in children of women who had undergone renal transplantation and IVF treatment were favourable.
Introduction
Since 1954 over 14 000 women have given birth after having had a solid organ transplantation (Humphreys et al., 2012) . Most large studies concerning this subject find high rates of preterm birth (PTB), low birthweight (LBW) and new-borns small for gestational age (SGA) (Källén et al., 2005; McKay and Josephson, 2006; Armenti et al., 2008; Deshpande et al., 2011 Deshpande et al., , 2012 . Hypertension and pre-eclampsia are common pregnancy complications, especially among renal transplant recipients (McKay and Josephson, 2006; Armenti et al., 2008; Deshpande et al., 2013) . No increase in birth defects has been found when the mothers have used the immunosuppressive agents cyclosporine, tacrolimus, prednisolone and azathioprine (Alston et al., 2001; McKay and Josephson 2006; Armenti et al., 2008; Deshpande et al., 2013) . However, with mycophenolic acid (MPA) agents, animal studies have demonstrated developmental toxicities, birth defects and increased rate of fetal death. The National Transplantation Pregnancy Registry (NTPR) in North America has reported that MPA exposure is associated with an increased incidence of spontaneous abortions and an increase in the rate of birth defects (to 24%), and a pattern of structural abnormalities in the fetus (Sifontis et al., 2006; Deshpande et al., 2013) . Therefore, the general recommendations from The European Best Practice Guidelines are to avoid the use of MPA in pregnancy (McKay and Josephson, 2006; Armenti et al., 2008) . One study found a high frequency of infant death (5% before the age of one) for deliveries after transplantation (Källén et al., 2005) . However, in that study a similarly high mortality was also found among children delivered to women a few years before transplantation, indicating that the morbidity of the woman was the major cause. A few studies have been conducted into longterm morbidity in the children of transplant recipients (Stanley et al., 1999; Lavelanet et al., 2006; Coscia et al., 2010) . In one of the studies (Stanley et al., 1999) data obtained from telephone interviews indicated that 24% of the children had developmental delays. However, subsequent neurocognitive testing was extremely limited. The other two studies Coscia et al., 2010) , which were based on telephone interviews or questionnaires with the parents, did not reveal any neurocognitive deficits or autoimmune diseases in the children later in life. Apart from that, the long-term consequences for the children of in utero exposure to immunosuppressive agents are virtually unknown (Tendron et al., 2002; Källén et al., 2005; McKay and Josephson, 2006) .
The first child conceived following in vitro fertilization (IVF) was born in 1978 (Steptoe and Edwards, 1978) and since then, it is estimated that worldwide .5 million babies have been born after IVF (Adamson et al., 2013) . IVF pregnancies are generally associated with an increased risk of PTB, LBW, SGA and perinatal mortality when compared with pregnancies after spontaneous conception (SC) (Helmerhorst et al., 2004; Bergh and Wennerholm, 2012; Pinborg et al., 2013) . This is mainly due to the high proportion of multiple pregnancies, but also singletons born after IVF have a 2-or 3-fold increased risk of PTB and LBW and 1-or 2-fold increased risk of SGA, compared with singletons born after SC (Helmerhorst et al., 2004; Jackson et al., 2004; McDonald et al., 2009) . The reasons for this are not completely understood but maternal characteristics such as age, parity and years of involuntary childlessness can explain, at least partly, these increased risks, while the role of IVF treatment is less clear (Bergh and Wennerholm, 2012) .
Thus, both organ transplantation and IVF are independently associated with increased risks of PTB, LBW, SGA and perinatal mortality. However, very few case reports (Lockwood et al., 1995; Furman et al., 1999; Tamaki et al., 2003; Fichez et al., 2008; Nouri et al., 2011) have been published on deliveries following IVF treatment in recipients of solid organ transplants.
Our primary aims were to study the obstetric outcome of pregnancies in women who had received transplanted organs, and long-term morbidity outcome in the children born to them after IVF treatment. Our secondary aims were to study the obstetric outcome of pregnancies in women who had received transplanted organs, and long-term morbidity outcome in the children born to them after SC.
Materials and Methods

Data sources
This was a population-based retrospective study carried out in Sweden. We used the following five registers: The National Quality Register of Assisted Reproduction (Q-IVF), the National Register in IVF for women giving birth, the Swedish Medical Birth Register (MBR), the National Patient Register (NPR) and the Swedish Cause of Death Register (CDR).
The purpose of Q-IVF is to continuously monitor outcomes and possible medical risks both for women who received IVF treatment and children born after this treatment. The register is thus a good platform for research. The Q-IVF Register started in 2007 and includes data of all IVF treatments in Sweden regardless of whether they lead to childbirth or not (http://www .ucr.uu.se/qivf/). Before 2007, IVF treatments were reported to the National Board of Health and Welfare in two registers, one with aggregated data from each IVF clinic and the other with identified data, which included only women who gave birth after IVF.
The MBR was established in 1973 and covers nearly all births in Sweden with very few exceptions (Cnattingius et al., 1990) . It contains information about maternal characteristics such as age, parity, height, weight, socioeconomic status, smoking habits and pregnancy complications. Furthermore, it contains information about the infant's sex, weight, length, head circumference and condition at birth and also includes data of live births, stillbirths and birth defects. Data on smoking and maternal height have been registered since 1983. The quality of MBR has been evaluated three times, in 1976 times, in , in 1988 times, in (Cnattingius et al., 1990 times, in ) and in 2001 times, in (www.socialstyrelsen.se/ publikationer2002/2002 . The register is considered to have a high degree of validity.
The NPR includes all in-patient care in Sweden. From 1987 it has covered the whole country, but before that year some Swedish counties did not participate. However, organ transplantation has been performed in a limited number of Swedish hospitals, all of which have reported to the NPR from early 1970s onwards. From 2001, the NPR has also covered outpatient visits, including day surgery and psychiatric disorders, treated by both private and public caregivers. Primary care is not yet covered in the NPR (Ludvigsson et al., 2011) .
The CDR includes all Swedish citizens who have died since 1952, either in the country or abroad, and who were registered in Sweden at the time of death (www.socialstyrelsen.se/register/dodsorsaksregistret).
All women in the study were identified by their personal identification number (PIN), a unique number allocated to each person living in Sweden.
Using this number, we were able to cross-link the five registers and identify the following groups: † Study group 1: women with an organ transplant who afterwards delivered a child following IVF treatment. † Study group 2: women with an organ transplant who afterwards delivered a child following SC. † Control group 3: (control group for singletons in study group 1): women without an organ transplant and with delivery after IVF (95 controls per case) matched for maternal age, parity and date of birth (only singletons). † Control group 4: (control group for singletons in study group 2):
women without an organ transplant and with deliveries after SC (20 controls per case) matched for maternal age, parity, year of delivery (only singletons).
The study period was from January 1973 to December 2012. Using the above-mentioned PIN all infants born to the women in these groups were identified in the MBR and then cross-linked with the NPR. This identified morbidity in infants from 7 days old that resulted in hospitalization or outpatient visits. Furthermore, they were cross-linked with the CDR in order to find possible deaths and cause of deaths.
Definitions † Preterm birth (PTB): birth ,37 weeks † Very preterm birth (VPTB): ,32 weeks † Low birthweight (LBW): weight at birth ,2500 g † Very low birthweight (VLBW): weight at birth ,1500 g † Small for gestational age (SGA): weight at birth ,22 SD (Marsál et al., 1996) † Child mortality:
(1) Stillbirth. The Swedish definition of stillbirth between 1973 and 30 June 2008, was intrauterine fetal death after 28 completed weeks of gestation. From 1 July 2008 the definition of stillbirth changed to intrauterine fetal death after 22 completed weeks of gestation. (2) Early neonatal death: death within 1 week of birth (3) Perinatal mortality: stillbirth and early neonatal mortality (4) Late neonatal death: death within 7-28 days after birth (5) 'Infant mortality': death within 1 year after birth (6) Mortality after 1 year: death 1 year after birth or later † Care at neonatal intensive care unit (NICU): We defined this as .7 NICU days after birth † Long-term morbidity in the children: morbidity resulting in hospitalization or outpatient visits after 7 days old. Specific codes from the International Classification of Diseases (ICD)-codes were selected (Supplementary Table SI) . † Birth defects were divided into those that were diagnosed at birth (found in MBR), at 6 months (found in MBR and NPR) and any birth defects that were diagnosed at follow-up visits (found in MBR and NPR) according to codes in ICD-8, ICD-9 and ICD-10 (Supplementary Table SI) . † Maternal complications according to specific ICD-8, ICD-9 and ICD-10 codes (Supplementary Table SI ) † Maternal mortality:
(1) 'Early mortality': death within 42 days after the delivery (2) 'Late mortality': death from 43 days up to 1 year after the delivery 
Statistical analysis
Ethical approval
Permission was given from the Regional Ethical Committee at the University of Gothenburg (Dnr 023-09, T431-09).
Results
Seven singletons (six women) and one set of twins were born after organ transplantation and IVF (group 1). All women in this group had renal transplants. After organ transplantation and SC, 240 singletons were born. There were 199 singletons after renal transplantation and SC (group 2). Forty-one singletons after other solid organ transplantations were excluded. Table I describes demographic data on singletons in the study and control groups. Table II shows the outcome in detail for all children born after renal transplantation and IVF. Maternal complications, neonatal outcome and long-term child morbidity for study and control groups are presented in Tables III -V . Statistical comparison between group 1 (renal transplantation and IVF) and group 3 (IVF-no organ transplantation) was not performed due to low numbers in group 1.
Maternal complications and outcome for children born after renal transplantation and IVF
Among singletons, two (29%) were PTB ,37 weeks. One of these (14%) was VPTB (27 weeks), had VLBW (672 g) and was SGA (Table II) . Two infants (29%) had birth defects of the ear. One woman developed preeclampsia (14%). Nobody in the group suffered from pregnancy-induced hypertension, gestational diabetes or placental abruption. The rate of Caesarean section was 85.7%. Mean age at follow-up of the children was 9.7 years (SD 4.2). Two children (29%) had been hospitalized and six children (86%) had had outpatient visits. Two children (29%) had been treated for acute infections in the upper respiratory tract and one child (14%) had been treated for acute bronchitis. Two children (29%) were later in life diagnosed with hyperactivity disorders. No child was diagnosed with developmental disorders, cerebral palsy or cancer. There were no cases of mortality either among the women or the children.
Maternal complications after renal transplantation
Maternal complications in study and control groups are presented in Table III . Significant differences in pre-eclampsia (23.6 versus 2.5%), gestational diabetes (2.5 versus 0.7%) and the proportion of Caesarean sections (61.3 versus 16.6%) were found between study group 2 and control group 4. However, no significant differences between the two groups were observed in pregnancy-induced hypertension, placental abruption, placenta previa, thromboembolic diseases or maternal mortality. Table IV presents the neonatal outcome in study and control groups. The rate of PTB (48.5%), LBW (43.7%) and SGA (21.2%) were significantly higher in infants born to women after renal transplantation than in infants born to women after SC and no transplantation. Furthermore, the proportion of children with neonatal morbidity (bronchopulmonary dysplasia, idiopathic respiratory distress syndrome, intraventricular haemorrhage, sepsis), stillbirth, early neonatal and infant mortality were all significantly higher. In study group 2, six of the nine children who died had extreme low birthweight (,1000 g) and died due to complications associated with severe immaturity or intrauterine growth restriction. No significant difference in the number of children with any birth defects was seen.
Neonatal outcome after maternal renal transplantation
Long-term follow-up of children born after renal transplantation
Mean age at follow-up of the children born after renal transplantation and SC was 14.7 (SD 9.4) years ( been hospitalized, 131 (65.8%), was significantly higher than in control group 4, where 1815 (45.6%) children had been hospitalized. The most common reason for medical care was respiratory diseases. The number of children with acute bronchitis, systemic lupus erythematosus and hyperactivity disorders was significantly higher in study group 2 than in control group 4. Otherwise, no significant differences in the long-term morbidity of the two groups of children were observed. There was no mortality in group 2 but 11 (0.3%) in control group 4 one year or later after birth.
Discussion
Overall, the obstetric outcome after renal transplantation and IVF was favourable. Outcomes were numerically in the same range as outcomes in women who had conceived spontaneously after renal transplantation, findings that were in agreement with earlier case reports ( 2008; Nouri et al., 2011) . However, the group of women who had experienced renal transplantation and then delivered children after IVF treatment was small, making it difficult to draw firm conclusions. Moreover, it is possible that the group of women who had had transplantation procedure and then IVF treatment were healthier than most transplant recipients, introducing a selection bias. Despite these shortcomings, the results are important as only a few case reports have previously been published on women with kidney or pancreas-kidney transplantation who have delivered children after IVF (Lockwood et al., 1995; Furman et al., 1999; Tamaki et al., 2003; Fichez et al., 2008; Nouri et al., 2011) . In our study as well as in previous case reports there are only pregnancies after IVF and kidney or pancreas-kidney transplants. One may speculate if the results can be generalized to all solid transplants groups. Assisted reproduction in transplant recipients is a controversial subject. Unwanted infertility affects many women (Jones and Toner, 1993) Marsál et al. (1996) . *Statistical comparison between group 1 and group 3 was not performed due to low numbers in group 1. A child can occur in one or several subgroups but only once in each subgroup. *Statistical comparison between T-IVF and IVF-No T was not performed due to low numbers in group 1. **In ICD-8 and ICD-9 the diagnosis otitis media belongs to the diseases of the nervous system. 2006). Infertility is often considered a serious threat to quality of life. An important question is how the selection of patients for IVF treatment after organ transplantation should be made. The couple need to be informed about the risks and alternatives, and the timing of pregnancy is also important. Transplant recipients should be in good health and, ideally, graft function should be good to excellent, stable and rejectionfree (Armenti et al., 2008) . Once pregnant, the woman needs to be monitored closely and by a multidisciplinary team, in the same way as spontaneous pregnancies in transplant recipients (Fichez et al., 2008; Armenti et al., 2008; Deshpande et al., 2013) . Careful selection of women with solid organ transplantation for IVF treatment will hopefully result in outcomes comparable to those in women who undergo solid organ transplantation and SC.
The results of the present study agree well with what is known in the literature about renal transplantation and SC: high frequencies of preeclampsia, PTB, LBW and SGA but no significant increase in birth defects (Källén et al., 2005; McKay and Josephson, 2006; Armenti et al., 2008; Deshpande et al., 2011 Deshpande et al., , 2012 . A major strength of the present study is that it is population-based and uses registers with high validity and without selection bias. Furthermore, it includes both short and long-term morbidity in the children. The proportion of children with neonatal morbidity and infant mortality was significantly higher in spontaneously conceived singletons delivered to women with renal transplantations, compared with singletons from women in the control group. However, it seemed that long-term morbidity of children who survived the first year of life did not appear to be particularly affected.
In conclusion, maternal and neonatal outcomes after renal transplantation and IVF were favourable. Outcomes were numerically in the same range as outcomes in women who had conceived spontaneously after renal transplantation. Long-term health outcomes in the children seemed satisfactory. However, caution is warranted due to the small study sample.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
